All In MedTech

FDA Clearance Tracker · P210006

Thoraflex™ Hybrid

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 19, 2022 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product codeBreakthrough

Decided

Apr 19, 2022

Approved

Time to decision

418 days

Received Feb 25, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P210006
Device name
Thoraflex™ Hybrid
Applicant location
Inchinnan
Received
Feb 25, 2021
Decided
Apr 19, 2022
Decision
Approved
Supplements
18 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QSK

FDA's approval statement

As written in FDA's record.

Approval for the Thoraflex Hybrid. The device is intended for the open surgical repair or replacement of damaged or diseased vessels of the aortic arch and descending aorta with or without involvement of the ascending aorta in cases of aneurysm and/or dissection.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code QSK (Hybrid stent graft, thoracic aortic lesion treatment).
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

Other decisions for Vascutek, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.